Women with RLS are more likely to have cardiovascular-related comorbidities than those without RLS.
The FDA has accepted Alnylam's New Drug Application for patisiran, and investigational drug for treating hereditary aTTR amyloidosis, for priority review.
The measurement may provide a dynamic measure of axonal damage in a disease in which neuropathy is the only neurologic manifestation.
For patients with restless leg syndrome, opioids may be very beneficial if taken in low daily doses.
Chronic pain symptoms in patients with PDPN are effectively reduced with spinal cord stimulation.
Secondary myofascial pain and mandibular limitations were reduced in the acupuncture and sham acupuncture groups immediately after treatment.
A probable diagnosis of fibromyalgia can be indicated with 2 simple tests in chronic pain patients.
Virtual reality and multisensory stimulation could play a role in rehabilitation for patients with spinal cord injury.
The mechanism for chemotherapy-induced peripheral neuropathy may have been uncovered.
In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.
Neurology Advisor Articles
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Comparing Reference Points for Deep Brain Stimulation Location in Parkinson Disease
- FDA Approves Clinical Decision Support Tool for Stroke
- US Will Produce Radioisotope for MRI, FDA Says
- Cognitive Decline in Men Linked to Low Serum Sodium
- Solanezumab Every 4 Weeks Does Not Significantly Affect Cognitive Decline in Alzheimer Disease